GRDNGuardian Pharmacy Services, Inc.Healthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $46.52 · now $46.52 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, GRDN has typically landed between $39.91 and $58.02 — a range of −14.2% to +24.7% from the issuance price $46.52.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

473 overlapping 1 month windows · 2024-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($46.52) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where GRDN has typically landed a month from the 2026-09-16 close of $46.52 — the range is history, not a prediction.

$39.91worst · -14.2%$58.02best · +24.7%
  • now $46.52 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $48.05 (+3.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $44.42–$51.69
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $39.91–$58.02
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 473 windows spanning 2024-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-05-19−25.8%−25.8%+0.0%
2025-05-20−24.2%−25.8%+0.0%
2025-09-11−22.7%−22.7%+0.0%
3 best
2025-08-11+45.8%+0.0%+45.8%
2025-08-08+44.4%−0.5%+44.5%
2024-10-25+42.6%+0.0%+42.6%

473 overlapping windows · 2024-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~2 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
100%
+6.5%
n=2
Feb
50%
−0.7%
n=2
Mar
100%
+9.3%
n=2
Apr
50%
+8.1%
n=2
May
50%
−5.5%
n=2
Jun
100%
+4.4%
n=2
Jul
0%
−3.8%
n=2
Aug
50%
+10.1%
n=2
Sep
50%
+12.4%
n=2
Oct
100%
+6.8%
n=2
Nov
100%
+21.8%
n=2
Dec
50%
−8.0%
n=2

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$48$232026-03-20: 10 insider sales, $419.3M — Bindley Capital Partners I, LLC, BINDLEY WILLIAM E, Salentine Thomas J Jr, Pharmacy Investors, LLC …2025-12-03: 1 insider purchase, $100K — COSLER STEVEN D2025-12: 1 open-market purchase, $100K2026-03: 10 open-market sales, $419.3M↑ buys↓ salestenPercentOwner Bindley Capital Partners I, LLC — Sale on 2026-03-20, filed 4 days after the tradedirector BINDLEY WILLIAM E — Sale on 2026-03-20, filed 4 days after the tradedirector Salentine Thomas J Jr — Sale on 2026-03-20, filed 4 days after the tradeother Pharmacy Investors, LLC — Sale on 2026-03-20, filed 4 days after the tradedirector Ackerman John — Sale on 2026-03-20, filed 4 days after the tradedirector Burke Fred — Sale on 2026-03-20, filed 4 days after the tradeofficer Forbes Kendall — Sale on 2026-03-20, filed 4 days after the tradeother Cardinal Equity Fund, L.P. — Sale on 2026-03-20, filed 4 days after the tradedirector Ackerman John — Sale on 2026-03-20, filed 4 days after the tradedirector Morris David K — Sale on 2026-03-20, filed 4 days after the tradedirector COSLER STEVEN D — Purchase on 2025-12-03, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-03-20Bindley Capital Partners I, LLCtenPercentOwnerSale3,570,677 @ $29.68$106.0M−44.4% of holding−7.4%not yet — horizon still open4,469,316Form 4 · filed 4 days after the trade
2026-03-20BINDLEY WILLIAM EdirectorSale3,570,677 @ $29.68$106.0M−44.4% of holding−7.4%not yet — horizon still open4,469,316Form 4 · filed 4 days after the trade
2026-03-20Salentine Thomas J JrdirectorSale3,570,677 @ $29.68$106.0M−44.4% of holding−7.4%not yet — horizon still open4,469,316Form 4 · filed 4 days after the trade
2026-03-20Pharmacy Investors, LLCotherSale827,636 @ $29.68$24.6M−44.4% of holding−7.4%not yet — horizon still open1,035,928Form 4 · filed 4 days after the trade
2026-03-20Ackerman JohndirectorSale827,636 @ $29.68$24.6M−44.4% of holding−7.4%not yet — horizon still open1,035,928Form 4 · filed 4 days after the trade
2026-03-20Burke FreddirectorSale671,432 @ $29.68$19.9M−44.4% of holding−7.4%not yet — horizon still open840,413Form 4 · filed 4 days after the trade
2026-03-20Forbes KendallofficerSale346,672 @ $29.68$10.3M−43.3% of holding−7.4%not yet — horizon still open453,256Form 4 · filed 4 days after the trade
2026-03-20Cardinal Equity Fund, L.P.otherSale275,728 @ $29.68$8.2M−44.4% of holding−7.4%not yet — horizon still open345,123Form 4 · filed 4 days after the trade
2026-03-20Ackerman JohndirectorSale275,728 @ $29.68$8.2M−44.4% of holding−7.4%not yet — horizon still open345,123Form 4 · filed 4 days after the trade
2026-03-20Morris David KdirectorSale187,855 @ $29.68$5.6M−42.5% of holding−7.4%not yet — horizon still open254,472Form 4 · filed 4 days after the trade
2025-12-03COSLER STEVEN DdirectorPurchase3,370 @ $29.61$100K+15.6% of holding+5.7%+29.9%24,984Form 4 · filed 2 days after the trade
2025-05-28BINDLEY WILLIAM EdirectorSale651,454 @ $20.16$13.1M−25.1% of holding−5.3%+21.4%1,939,817Form 4 · filed 1 day after the trade
2025-05-28Bindley Capital Partners I, LLCtenPercentOwnerSale651,454 @ $20.16$13.1M−25.1% of holding−5.3%+21.4%1,939,817Form 4 · filed 1 day after the trade
2025-05-28Salentine Thomas J JrdirectorSale651,454 @ $20.16$13.1M−25.1% of holding−5.3%+21.4%1,939,817Form 4 · filed 1 day after the trade
2025-05-28Pharmacy Investors, LLCotherSale150,998 @ $20.16$3.0M−25.1% of holding−5.3%+21.4%449,624Form 4 · filed 125 days after the trade
2025-05-28Ackerman JohndirectorSale150,998 @ $20.16$3.0M−25.1% of holding−5.3%+21.4%449,624Form 4 · filed 1 day after the trade
2025-05-28Burke FreddirectorSale138,705 @ $20.16$2.8M−25.1% of holding−5.3%+21.4%413,019Form 4 · filed 1 day after the trade
2025-05-28Morris David KdirectorSale68,547 @ $20.16$1.4M−24.2% of holding−5.3%+21.4%214,495Form 4 · filed 1 day after the trade
2025-05-28Forbes KendallofficerSale64,991 @ $20.16$1.3M−24.2% of holding−5.3%+21.4%203,906Form 4 · filed 1 day after the trade
2025-05-28Ackerman JohndirectorSale50,305 @ $20.16$1.0M−25.1% of holding−5.3%+21.4%149,794Form 4 · filed 1 day after the trade
2025-05-28Cardinal Equity Fund, L.P.otherSale50,305 @ $20.16$1.0M−25.1% of holding−5.3%+21.4%149,794Form 4 · filed 125 days after the trade
2025-05-27Bindley Capital Partners I, LLCtenPercentOwnerSale3,508,905 @ $20.16$70.7M−57.5% of holding−8.2%+15.8%2,591,271Form 4 · filed 2 days after the trade
2025-05-27BINDLEY WILLIAM EdirectorSale3,508,905 @ $20.16$70.7M−57.5% of holding−8.2%+15.8%2,591,271Form 4 · filed 2 days after the trade
2025-05-27Salentine Thomas J JrdirectorSale3,508,905 @ $20.16$70.7M−57.5% of holding−8.2%+15.8%2,591,271Form 4 · filed 2 days after the trade
2025-05-27Pharmacy Investors, LLCotherSale813,318 @ $20.16$16.4M−57.5% of holding−8.2%+15.8%600,622Form 4 · filed 126 days after the trade
2025-05-27Ackerman JohndirectorSale813,318 @ $20.16$16.4M−57.5% of holding−8.2%+15.8%600,622Form 4 · filed 2 days after the trade
2025-05-27Burke FreddirectorSale747,102 @ $20.16$15.1M−57.5% of holding−8.2%+15.8%551,724Form 4 · filed 2 days after the trade
2025-05-27Morris David KdirectorSale369,212 @ $20.16$7.4M−56.6% of holding−8.2%+15.8%283,042Form 4 · filed 2 days after the trade
2025-05-27Forbes KendallofficerSale350,058 @ $20.16$7.1M−56.6% of holding−8.2%+15.8%268,897Form 4 · filed 2 days after the trade
2025-05-27Ackerman JohndirectorSale270,958 @ $20.16$5.5M−57.5% of holding−8.2%+15.8%200,099Form 4 · filed 2 days after the trade
2025-05-27Cardinal Equity Fund, L.P.otherSale270,958 @ $20.16$5.5M−57.5% of holding−8.2%+15.8%200,099Form 4 · filed 126 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

123 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-05-05Patchett Mary SuedirectorAward / grant4,02815,071Form 4
2026-05-05COSLER STEVEN DdirectorAward / grant4,02829,012Form 4
2026-05-05LEWIS RANDALL JdirectorAward / grant4,02815,071Form 4
2026-03-28Morris David KdirectorOption exercise641,869896,341Form 4
2026-03-28Salentine Thomas J JrdirectorOption exercise6,100,17510,569,491Form 4
2026-03-28Salentine Thomas J JrdirectorOption exercise6,100,1756,100,175Form 4
2026-03-28Cardinal Equity Fund, L.P.otherOption exercise471,057816,180Form 4
2026-03-28Cardinal Equity Fund, L.P.otherOption exercise471,057471,057Form 4
2026-03-28BINDLEY WILLIAM EdirectorOption exercise6,100,17510,569,491Form 4
2026-03-28BINDLEY WILLIAM EdirectorOption exercise6,100,1756,100,175Form 4
2026-03-28Pharmacy Investors, LLCotherOption exercise1,413,9392,449,867Form 4
2026-03-28Pharmacy Investors, LLCotherOption exercise1,413,9391,413,939Form 4
2026-03-28Burke FreddirectorOption exercise1,298,8262,139,239Form 4
2026-03-28Burke FreddirectorOption exercise1,298,8261,298,825Form 4
2026-03-28Ackerman JohndirectorOption exercise1,413,9392,449,867Form 4
2026-03-28Ackerman JohndirectorOption exercise1,413,9391,413,939Form 4
2026-03-28Bindley Capital Partners I, LLCtenPercentOwnerOption exercise6,100,17510,569,491Form 4
2026-03-28Bindley Capital Partners I, LLCtenPercentOwnerOption exercise6,100,1756,100,175Form 4
2026-03-28Morris David KdirectorOption exercise641,869896,341Form 4
2026-03-28Morris David KdirectorOption exercise641,869641,870Form 4
2026-03-28Forbes KendallofficerOption exercise608,5701,061,826Form 4
2026-03-28Forbes KendallofficerOption exercise608,570608,570Form 4
2026-03-28Burke FreddirectorOption exercise1,298,8262,139,239Form 4
2026-03-28Burke FreddirectorOption exercise1,298,8261,298,825Form 4
2026-03-28Cardinal Equity Fund, L.P.otherOption exercise471,057816,180Form 4
2026-03-28Cardinal Equity Fund, L.P.otherOption exercise471,057471,057Form 4
2026-03-28Morris David KdirectorOption exercise641,869641,870Form 4
2026-03-28Salentine Thomas J JrdirectorOption exercise6,100,1756,100,175Form 4
2026-03-28Salentine Thomas J JrdirectorOption exercise6,100,17510,569,491Form 4
2026-03-28Ackerman JohndirectorOption exercise1,413,9392,449,867Form 4
2026-03-28Ackerman JohndirectorOption exercise471,057816,180Form 4
2026-03-28Ackerman JohndirectorOption exercise1,413,9391,413,939Form 4
2026-03-28Ackerman JohndirectorOption exercise471,057471,057Form 4
2026-03-28BINDLEY WILLIAM EdirectorOption exercise6,100,17510,569,491Form 4
2026-03-28BINDLEY WILLIAM EdirectorOption exercise6,100,1756,100,175Form 4
2026-03-28Bindley Capital Partners I, LLCtenPercentOwnerOption exercise6,100,17510,569,491Form 4
2026-03-28Bindley Capital Partners I, LLCtenPercentOwnerOption exercise6,100,1756,100,175Form 4
2026-03-28Pharmacy Investors, LLCotherOption exercise1,413,9392,449,867Form 4
2026-03-28Pharmacy Investors, LLCotherOption exercise1,413,9391,413,939Form 4
2026-03-28Forbes KendallofficerOption exercise608,5701,061,826Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.